Retatrutide 20mg – Research Peptide

Retatrutide 20mg research peptide is supplied as a high-purity synthetic triple-agonist compound intended strictly for laboratory investigation of incretin receptor signaling pathways and metabolic regulatory systems. In controlled research environments, Retatrutide is studied for its interaction with GLP-1, GIP, and glucagon receptor pathways and the resulting intracellular signaling mechanisms.

This 20mg presentation provides a standardized laboratory format suitable for experimental modeling and metabolic pathway analysis.

We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.

Read the full comparison here.

Research Applications

Retatrutide is evaluated in laboratory research for:

• GLP-1 receptor signaling pathway studies• GIP receptor interaction research• Glucagon receptor pathway investigation• Metabolic regulatory signaling analysis• Multi-receptor peptide pathway modeling

Its triple-agonist receptor interaction differentiates it from dual-receptor metabolic peptides studied in other research frameworks.

Product Specifications

Compound: Retatrutide

Strength: 20mg per vial

Form: Lyophilized powder

Purity: Research grade (see COA)

Storage: Refrigerated storage recommended

Intended Use: Laboratory Research Use Only

Certificate of Analysis (COA)

Each batch of Retatrutide 20mg research peptide is verified for purity and identity.

Current Active Batch: # ERL-2501-B023-T

View the full Certificate of Analysis here:

View Current COA

Research Use Notice

This compound is supplied strictly for laboratory research use only.

Not for human or animal consumption.

Related Metabolic Research Peptides

Researchers studying Retatrutide may also examine:

• Tirzepatide 30mg– Research Peptide

• AOD-9604– Research Peptide

• MOTS-C– Research Peptide